MedPath

Episiotomy wound healing by Tiktadyam ghrita and Ropana taila

Phase 3
Not yet recruiting
Conditions
Noninflammatory disorder of vulvaand perineum, unspecified. Ayurveda Condition: SADYOVRANAH,
Registration Number
CTRI/2023/08/056802
Lead Sponsor
Dr Nidhi
Brief Summary

Episiotomy or periotomy which can be correlated to sadyovrana is a planned incision on the perineum and posterior vaginal wall during second stage of labor. Episiotomy provides ease of child birth by widening the vaginal opening and it also protects tone of perineum and prevents undesired vaginal fissures .Episiotomy is the one of the most commonly employed procedures during women deliveries in hospital of India.

The rate of episiotomy was found to be 93.3% in primipara and 30.2% in multi para women. After episiotomy the concern is wound healing.

Acharyas have mentioned lepana i.e. tropical application of taila and ghrita in chikitsa of vrana.Hence Tiktadyam ghrita and Ropana taila which is mentioned in vrana chikitsa having vrana shodhana and vrana ropana properties are selected for the current study

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
Female
Target Recruitment
40
Inclusion Criteria

Primi and multi gravida who will undergo normal vaginal delivery and had episiotomy (1st and 2nd degree).

Exclusion Criteria

Ventouse and forceps delivery 3rd and 4th degree perineal tear perineal lacerations any systemic disease subject tested positive for HIV HBSAG VDRL.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Faster wound healing on the basis of REEDA ScaleBaseline,7th day,15th day,21 day
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

SDM Institute of Ayurveda and Hospital

🇮🇳

Bangalore, KARNATAKA, India

SDM Institute of Ayurveda and Hospital
🇮🇳Bangalore, KARNATAKA, India
Dr Nidhi
Principal investigator
8178659756
nidhi@sdmayurbangalore.in

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.